Stroke Clinical Trial
Official title:
Understanding the Role of Autoimmune Disorders on the Initial Presentation of Cardiovascular Disease: a CALIBER Proposal Using Linked GPRD-MINAP-HES Data
Autoimmune diseases are diseases in which inappropriate immune responses that have the
capability of harming host cells play an important role. Evidence suggests that the presence
of certain autoimmune diseases such as rheumatoid arthritis or systematic lupus
erythematosus increase the risk of cardiovascular disease (CVD). However, this evidence is
inconsistent for autoimmune disorders and no systematic approach has been previously used to
study the relationship between a range of common autoimmune disorders and specific forms of
cardiovascular diseases such as myocardial infarction, intracerebral and subarachnoid
haemorrhage, or venous thrombosis.
The investigators will use linked electronic health records to investigate whether commonly
diagnosed autoimmune disorders are associated with increased risk of CVD development and
whether effects differ in men and women and change with age.
Status | Active, not recruiting |
Enrollment | 200000 |
Est. completion date | June 2015 |
Est. primary completion date | December 2014 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - One year prior to study entry - 18 years or older - Recorded sex - Free of symptomatic cardiovascular disease at entry Exclusion Criteria: - Prior cardiovascular disease |
Observational Model: Cohort, Time Perspective: Retrospective
Country | Name | City | State |
---|---|---|---|
United Kingdom | University College London | London |
Lead Sponsor | Collaborator |
---|---|
University College, London | National Institute for Health Research, United Kingdom, Wellcome Trust |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Cumulative incidence per autoimmune disease status | Associations studied: overall by sex by age group |
Followed for the duration of general practice registration between date of eligibility and date of administrative censoring, outcome occurrence or death (expected median of 5 years) | No |
Primary | Rate ratios for the associations between presence of autoimmune disorders and initial presentation of myocardial infarction | Associated studies: overall, by sex, by age group |
Followed for the duration of general practice registration between date of eligibility and date of administrative censoring, outcome occurrence or death (expected median of 5 years) | No |
Primary | Rate ratios for the associations between presence of autoimmune disorders and initial presentation of stroke | Associated studies: overall, by sex, by age group |
Followed for the duration of general practice registration between date of eligibility and date of administrative censoring, outcome occurrence or death (expected median of 5 years) | No |
Primary | Rate ratios for the associations between presence of autoimmune disorders and initial presentation of stroke and venous thrombosis | Associated studies: overall, by sex, by age group |
Followed for the duration of general practice registration between date of eligibility and date of administrative censoring, outcome occurrence or death (expected median of 5 years) | No |
Secondary | Hazard ratios for the association between the presence of autoimmune disease and the initial presentation of stable angina | Associations studied: overall by sex by age group |
Followed for the duration of general practice registration between date of eligibility and date of administrative censoring, outcome occurrence or death (expected median of 5 years) | No |
Secondary | Hazard ratios for the association between the presence of autoimmune disease and the initial presentation of unstable angina | Associated studies: overall, by sex, by age group |
Followed for the duration of general practice registration between date of eligibility and date of administrative censoring, outcome occurrence or death (expected median of 5 years) | No |
Secondary | Hazard ratios for the association between the presence of autoimmune disease and the initial presentation of heart failure | Associated studies: overall, by sex, by age group |
Followed for the duration of general practice registration between date of eligibility and date of administrative censoring, outcome occurrence or death (expected median of 5 years) | No |
Secondary | Hazard ratios for the association between the presence of autoimmune disease and the initial presentation of peripheral arterial disease | Associated studies: overall, by sex, by age group |
Followed for the duration of general practice registration between date of eligibility and date of administrative censoring, outcome occurrence or death (expected median of 5 years) | No |
Secondary | Hazard ratios for the association between the presence of autoimmune disease and the initial presentation of transient ischemic attack | Associated studies: overall, by sex, by age group |
Followed for the duration of general practice registration between date of eligibility and date of administrative censoring, outcome occurrence or death (expected median of 5 years) | No |
Secondary | Hazard ratios for the association between the presence of autoimmune disease and the initial presentation of abdominal aortic aneurysm | Associated studies: overall, by sex, by age group |
Followed for the duration of general practice registration between date of eligibility and date of administrative censoring, outcome occurrence or death (expected median of 5 years) | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04043052 -
Mobile Technologies and Post-stroke Depression
|
N/A | |
Recruiting |
NCT03869138 -
Alternative Therapies for Improving Physical Function in Individuals With Stroke
|
N/A | |
Completed |
NCT04101695 -
Hemodynamic Response of Anodal Transcranial Direct Current Stimulation Over the Cerebellar Hemisphere in Healthy Subjects
|
N/A | |
Completed |
NCT04034069 -
Effects of Priming Intermittent Theta Burst Stimulation on Upper Limb Motor Recovery After Stroke: A Randomized Controlled Trial
|
N/A | |
Terminated |
NCT03052712 -
Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies
|
N/A | |
Completed |
NCT00391378 -
Cerebral Lesions and Outcome After Cardiac Surgery (CLOCS)
|
N/A | |
Recruiting |
NCT06204744 -
Home-based Arm and Hand Exercise Program for Stroke: A Multisite Trial
|
N/A | |
Active, not recruiting |
NCT06043167 -
Clinimetric Application of FOUR Scale as in Treatment and Rehabilitation of Patients With Acute Cerebral Injury
|
||
Active, not recruiting |
NCT04535479 -
Dry Needling for Spasticity in Stroke
|
N/A | |
Completed |
NCT03985761 -
Utilizing Gaming Mechanics to Optimize Telerehabilitation Adherence in Persons With Stroke
|
N/A | |
Recruiting |
NCT00859885 -
International PFO Consortium
|
N/A | |
Recruiting |
NCT06034119 -
Effects of Voluntary Adjustments During Walking in Participants Post-stroke
|
N/A | |
Completed |
NCT03622411 -
Tablet-based Aphasia Therapy in the Chronic Phase
|
N/A | |
Completed |
NCT01662960 -
Visual Feedback Therapy for Treating Individuals With Hemiparesis Following Stroke
|
N/A | |
Recruiting |
NCT05854485 -
Robot-Aided Assessment and Rehabilitation of Upper Extremity Function After Stroke
|
N/A | |
Active, not recruiting |
NCT05520528 -
Impact of Group Participation on Adults With Aphasia
|
N/A | |
Completed |
NCT03366129 -
Blood-Brain Barrier Disruption in People With White Matter Hyperintensities Who Have Had a Stroke
|
||
Completed |
NCT05805748 -
Serious Game Therapy in Neglect Patients
|
N/A | |
Completed |
NCT03281590 -
Stroke and Cerebrovascular Diseases Registry
|
||
Recruiting |
NCT05993221 -
Deconstructing Post Stroke Hemiparesis
|